Loading events...
Innate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate (ADC) program at clinical stage. The event will be held in New York in a hybrid format to share the latest scientific and clinical advancements related to Nectin-4 and its potential in cancer treatment.
Wednesday, February 5, 2025
New York, USA
Innate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate (ADC) program at clinical stage. The event will be held in New York in a hybrid format to share the latest scientific and clinical advancements related to Nectin-4 and its potential in cancer treatment.
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York takes place on Wednesday, February 5, 2025.
Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York is held in New York, USA.
Pricing information is available on the event website.
Innate Pharma announces Nectin-4 antibody drug conjugate investor and analyst event in New York is designed for healthcare professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox